Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.1 (
chymotrypsin
)
10,938
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chinese hamster lung cells resistant to Adriamycin were labeled with inorganic [32P]orthophosphate and thereafter incubated with low levels of N-ethylmaleimide. Plasma membranes and endoplasmic reticulum were isolated and the phosphorylated proteins were analyzed after polyacrylamide gel electrophoresis. The results demonstrate that both plasma membranes and endoplasmic reticulum from resistant cells contain two highly phosphorylated proteins [Mr 180,000 (p180) and Mr 220,000 (p220)] which are present in very low levels in these membrane fractions prepared from drug sensitive cells. p220 is present in much higher levels in the endoplasmic reticulum as compared to the plasma membranes whereas p180 is equally distributed in these two membrane fractions. When resistant cells revert to drug sensitivity there is a parallel loss in the phosphorylation levels of p180 and p220. Labeling of membrane proteins with 125I in the presence of chloramine-T also reveals that p180 and p220 are present in significantly greater levels in resistant membranes as compared to similar fractions prepared from drug sensitive cells. Partial digests of phosphorylated p180 and p220 produced with
chymotrypsin
or V8 protease reveal that each protein has a distinct phosphopeptide pattern. Both p180 and p220 are phosphorylated exclusively at serine residues. The results of this study therefore suggest that resistance to Adriamycin in Chinese hamster lung cells requires the involvement of two distinct proteins which are both bound to cell membranes.
Cancer
Res 1985 Dec
PMID:Evidence for the involvement of two distinct membrane proteins in adriamycin resistance in Chinese hamster lung cells. 406 66
Feline leukemia virus DNA polymerase was purified by ion-exchange and nucleic acid affinity chromatographies. The enzyme consists of a single polypeptide chain of mol. wt. approx. 72,000 as determined by both glycerol density gradient centrifugation and SDS-polyacrylamide gel electrophoresis. The preferred divalent cation for DNA synthesis is Mn2+ on a variety of template-primers, and its optimum concentration appears to be significantly lower than reported results of other mammalian type-C viral enzymes. The purified enzyme also contained RNAase H activity. Both DNA polymerase and RNAase H activities appear to reside on the same molecule as demonstrated by the copurification of both activities through various purification steps. The divalent cation requirement for maximum activity of RNAase H is also similar to that of the DNA polymerase. RNAase H without detectable polymerase activity was generated by a limited
chymotrypsin
digestion of the purified reverse transcriptase. This RNAase H activity was inhibited equally effectively as RNAase H in the intact reverse transcriptase by antisera prepared against reverse transcriptase of feline leukemia virus. These results indicate that the RNAase H catalytic activity of reverse transcriptase is distinct from the polymerase portion of the molecule. Since the RNAase H activity appears to be more stable, the measurement of RNAase H activity with a proper antibody might be useful for assaying tumor cells for the presence of the viral enzyme.
Cancer
Lett 1980 Sep
PMID:Biochemical and immunological properties of the DNA polymerase and RNAase H activities of purified feline leukemia virus reverse transcriptase. 615 69
EDC1, a glycoprotein with a molecular weight of 27,500, was purified from the urine of a leukemic patient, and a radioimmunoassay was developed to use as an immunodiagnostic tool for
cancer
. Previous studies showed that up to 60% of patients with disseminated neoplastic diseases excreted 100 to 500 mg of EDC1 per day. This protein was immunologically related to inter-alpha-trypsin inhibitor (IATI; M.W. 170,000), a glycoprotein normally present in plasma. EDC1, like IATI, inhibited trypsin and
chymotrypsin
. EDC1 and IATI have now been found to inhibit the incorporation of thymidine into DNA of normal lymphocytes transformed by phytohemagglutinin. In the presence of 1000 micrograms of EDC1 or 300 micrograms of IATI, incorporation of thymidine by cells was totally inhibited. These proteins were not cytotoxic, did not affect transport of thymidine across the membrane, formed no complex with phytohemagglutinin, and did not compete with phytohemagglutinin for its binding sites. It is proposed that EDC1 and IATI may exert this effect by inhibiting a protease required for blastogenesis.
Cancer
Res 1980 Nov
PMID:Effect of plasma inter-alpha trypsin inhibitor and cancer-related glycoprotein EDC1 on phytohemagglutinin-induced thymidine uptake in lymphocytes. 616 47
Rat and hamster pancreatic ducts were isolated by digestion with collagenase plus
chymotrypsin
and were cultured for eight weeks in an agarose matrix. Freshly isolated and cultured ducts were characterized morphologically and biochemically. The in vivo morphology of the ducts was maintained in vitro, although certain differences were noted. Both interlobular and intralobular ducts could be identified. gamma-Glutamyltranspeptidase and Mg-ATPase were stable enzymatic activities of the ducts of both species; alkaline phosphatase persisted only in the hamster ducts. Carbonic anhydrase and (Na + K)ATPase were minor activities of the rat ducts. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the rat ducts suggested that actin was the major duct peptide and that the major zymogens were greatly diminished. These results demonstrate that pancreatic ducts can be maintained in vitro and can be used for biochemical studies of this minor pancreatic tissue type.
Cancer
1981 Mar 15
PMID:Morphologic and biochemical characteristics of isolated and cultured pancreatic ducts. 616 52
An alpha-macroglobulin (AMG) of similar size and proteinase-binding activity as those of human, alpha 2-macroglobulin was purified to homogeneity from mouse plasma. Even after additional purification steps, AMG still retains a growth-inhibitory activity and a more complex subunit structure than does human alpha 2-macroglobulin. AMG can inhibit the DNA synthesis of all types of murine tumor cells tested in vitro. This activity is cytostatic, dose dependent, and unaffected by the serum concentration in culture. Because this inhibitory activity is resistant to heat, pH 3, and methylamine, it is apparently unrelated to the proteinase-binding activity which is labile to all these treatments. Furthermore, in contrast to the proteinase-binding activity, the inhibitory activity can be partially removed from AMG by acid dialysis. Gel filtration of the dialysate yields two fractions (Mr 12,000 and 1,000 to 5,000) which potently inhibit murine tumor cells but stimulate both the B- and T-lymphocyte reactivities to mitogens in vitro. The growth-inhibitory activities in these fractions are resistant to digestions by
chymotrypsin
, RNase, and DNase. We conclude from this study that AMG does not inhibit tumor growth by virtue of its proteinase-binding activity; it may inhibit tumor cells via the small biomediators it carries.
Cancer
Res 1982 May
PMID:Characterization of growth-inhibitory activities associated with an alpha-macroglobulin of mice. 617 96
Glucocorticoid-resistant (CR), in contrast to glucocorticoid-sensitive (CS), mouse lymphoma P1798 was shown to lack antiglucocorticoid receptor immunoactivity. Antibodies raised against the purified rat liver glucocorticoid receptor (GR) cross-reacted with the GR from CS, but not with the GR from CR, P1798 lymphoma. Using highly specific antisera against the GR in an indirect competitive enzyme-linked immunosorbent assay, it was demonstrated that
alpha-chymotrypsin
digestion of the GR from CS P1798 lymphoma caused a separation of a "resistant-like" nonimmunogenic steroid and DNA-binding domain (Stokes' radius, 3.3 nm) from an immunoactive domain (Stokes' radius, 2.6 nm). In contrast to CS P1798 lymphoma, neither before nor after
alpha-chymotrypsin
digestion, immunoactivity could be found in the cytosol from CR P1798 lymphoma. This was assayed after chromatography on DNA-cellulose or gel filtration on Agarose A (0.5 m). These results suggest that the domain of the CS GR containing the immunoactive determinant(s), normally removed by limited proteolysis by
alpha-chymotrypsin
, appears to be missing in CR P1798 lymphoma cytosol. It seems that this domain plays an important role in the mechanism of action of glucocorticoids. This might suggest that a mutation has occurred affecting the genome resulting in defective transcription of the receptor gene(s) in CR P1798 lymphoma.
Cancer
Res 1983 Jul
PMID:Absence in glucocorticoid-resistant mouse lymphoma P1798 of a glucocorticoid receptor domain responsible for biological effects. 618 92
Ehrlich ascites cells in mice have been shown to have a cell-surface trypsin-like neutral protease (TLNP) with proteolytic and beta-naphthylamidase activity. This activity is inhibited by low-mol.-wt inhibitors of trypsin but not by 11 high-mol.-wt inhibitors of trypsin in free solution. We believe that lack of inhibition is due to protection given to the enzyme by the chemical environment of the cell surface. These cells were demonstrated to export a collagenase zymogen which has been shown to be activated by the cell-surface TLNP. When this protease was completely inhibited by low-mol.-wt inhibitors of trypsin,
chymotrypsin
was used to activate the collagenase zymogen exported by Ehrlich ascites cells. Examination of the products of collagenolysis at 15 degrees C demonstrated the expected 3/4- and 1/4-length alpha-chain fragments derived from monomeric collagen, confirming that collagenase was one of the enzymes responsible for lysis of the collagen fibrils in the test system.
Br J
Cancer
1980 Nov
PMID:A trypsin-like neutral protease on Ehrlich ascites cell surfaces: its role in the activation of tumour-cell zymogen of collagenase. 625 67
We have demonstrated that incubation of rat liver microsomes with N-hydroxy-2-acetylaminofluorene (N-OH-AAF) leads to formation of a 2-nitrosofluorene-membrane lipid adduct. This adduct exists as a nitroxyl free radical, termed N-O-LAF, in its oxidized state. When microsomes were incubated with the sulfhydryl binding agent, rho-hydroxymercuribenzoate, a larger amount of N-OL-LAF formed. We interpret this as a slowdown in the rate of endogenous chemical reduction of carcinogen-membrane lipid adduct. In this paper we present evidence that N-OH-AAF is deacetylated by a microsomal enzyme to form N-hydroxy-2-aminofluorene and this is then oxidized to 2-nitrosofluorene which adds covalently to membrane lipid double bonds to form N-O-LAF. Various antioxidants, peroxidase inhibitors, and P450 substrates and inhibitors were ineffective in altering the amount of N-O-LAF formed from N-OH-AAF; but two esterase inhibitors, dietyl-rho-nitrophenylphosphate and alpha-toluene-sulfonyl fluoride, prevented N-O-LAF formation. Of the following purified enzymes tested: porcine liver carboxyl esterase, pepsin,
chymotrypsin
, cathepsin D, ficin, papain, leucine aminopeptidase, Naja naja phospholipase, acetylcholinesterase (type I), trypsin (type I and V) and epoxide hydrase; only carboxyl esterase was effective in deacetylating N-OH-AAF.
Cancer
Biochem Biophys 1980
PMID:The deacetylation of N-hydroxy-2-acetylaminofluorene by rat liver microsomes and carboxyl esterase. 626 Mar 32
This paper describes the isolation and partial characterization of a collagen cell attachment protein from the spent culture medium of rat hepatoma cells. When compared with serum fibronectin, this attachment protein differed in several biochemical parameters. The hepatoma attachment protein was partially purified by adsorbing and eluting from an inorganic gel, magnesium oxide. Cell adhesive activity may routinely recovered at levels of 10 to 30%, and a 2000-fold purification was attained. The hepatoma attachment protein was shown to be sensitive to trypsin and
chymotrypsin
, to be heat inactivated at 61 degrees, to have a molecular weight of 58,000, to have an isoelectric point of 4.1, to show an electrophoretic mobility on cellulose acetate of approximately one-half that of fibronectin, and not to cross-react with antifibronectin antisera.
Cancer
Res 1981 Oct
PMID:Collagen cell attachment protein from rat hepatoma cells. 626 32
The possibility that pancreatic secretory abnormalities might precede the appearance of pancreatic neoplasms and thus provide clues to early detection of this
malignancy
has been investigated in an animal model. Syrian golden hamsters were treated with bis-(2-oxopropyl)-N-nitrosamine on two successive weeks (2 mg/100 g body weight/week). Pancreatic secretions from treated and untreated control animals were studied at approximately monthly intervals. The animals were anesthetized, their pancreatic ducts cannulated, and basal pancreatic juice collected for 30 min. Pancreatic secretion was then stimulated by sequential intravenous injection of secretin (50 ng/100 g) and C-terminal octapeptide of cholecystokinin (4 ng/100 g) 1 hr later. Four consecutive 15-min collections of fluid were made following secretin stimulation and four additional collections after CCK administration. Each collection was examined for volume, total protein, trypsin,
chymotrypsin
, elastase, arylsulfatase, beta-D-glucuronidase, alpha-D-glucosidase, and leucine naphthylamidase. In addition two trypsinogen variants present in pancreatic secretions were determined. The pancreas and other organs were removed and examined histologically at the end of each experiment. Cytological atypia appeared 3 months, ductal hyperplasia 4 months, and pancreatic neoplasms 6 months after the last injection of carcinogen. Striking decreases in flow rate and output of trypsin and
chymotrypsin
were observed several months prior to the appearance of histologically recognizable pancreatic tumors. By contrast, output of beta-D-glucuronidase and alpha-D-glucosidase in pancreatic juice increased markedly in the last 2 months preceding the emergence of neoplasms. The diagnostic significance of these premalignant abnormalities is illustrated most dramatically in the form of ratios of lysosomal to digestive enzymes, such as beta-D-glucuronidase-trypsin or alpha-D-glucosidase-
chymotrypsin
. Highly significant increases in these ratios were observed consistently, not only in hamsters with pancreatic neoplasms, but also in animals with preneoplastic lesions (ductular hyperplasia) which preceded
malignancies
by about 2 months.
...
PMID:Pancreatic secretory abnormalities precede appearance of tumors of the pancreas in hamsters treated with bis-(2-oxopropyl)-N-nitrosamine. 630 6
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>